Akeso, Inc. (HKG:9926)
97.60
+2.40 (2.52%)
Jun 24, 2025, 4:08 PM HKT
Akeso Employees
Akeso had 3,035 employees as of December 31, 2024. The number of employees increased by 257 or 9.25% compared to the previous year.
Employees
3,035
Change (1Y)
257
Growth (1Y)
9.25%
Revenue / Employee
744.73K HKD
Profits / Employee
-180.41K HKD
Market Cap
87.60B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
Innovent Biologics | 5,659 |
JD Health International | 3,564 |
WuXi Biologics | 12,575 |
Sino Biopharmaceutical | 24,379 |
CSPC Pharmaceutical Group | 21,400 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
Akeso News
- 22 days ago - Chinese biotech firm Akeso sinks after US partner’s cancer-drug setback - South China Morning Post
- 2 months ago - Why Is Summit Therapeutics Stock Trading Higher On Monday? - Benzinga
- 2 months ago - China’s Akeso, hailed as biotech’s ‘DeepSeek moment’, falls despite nod for cancer drug - South China Morning Post
- 2 months ago - What's Going On With Summit Therapeutics Stock On Friday? - Benzinga
- 2 months ago - Why Is Summit Therapeutics Stock Soaring On Wednesday? - Benzinga
- 2 months ago - Akeso (9926) Poised for Growth Despite Current Undervaluation - GuruFocus
- 2 months ago - Bullish On Akeso's Ivonescimab, But Valuation And Geopolitical Risks Remain - Seeking Alpha
- 2 months ago - Why This Chinese Biotech Could Be Pharma's DeepSeek - Benzinga